Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 72266-261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 72266-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

FDA Label Image

Container (Container)

Container (Container)
This text provides detailed information about a Levothyroxine Sodium for Injection medication. Each vial contains 100 mcg of the active ingredient. It is intended for intravenous use as a single-dose vial, with instructions to discard any unused portion. The medication is manufactured by FOSUNPHARMA and is lyophilized and preservative-free. It is important to store the product at 20°C to 25°C (66°F to 77°F) and protect it from light. Reconstitution directions are provided for mixing the medication with 0.9% Sodium Chloride Injection. The product is distributed by Fosun Pharma USA Inc in Princeton, NJ, and it is made in India.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.